In the US, the total available market for our device is the 140,000 new annual lower limb (LL) amputations and the 1,400,000 living LL amputees (AOPA).  Considering the rest of world, the total market is approximately double these figures and total living LL amputees is expected to double by 2050. Fully 80% of LL amputees have neuropathy which limits their ability to adjust the socket fit as the limb volume changes throughout the day.      


We are engineering a product for retrofit into all existing sockets, a second product that will fit all new sockets and a product that will work with check sockets.   

For a comprehensive presentation about our opportunity, please use the Contact page to reach us.